Healthpeak Properties (NYSE:DOC) Issues FY 2026 Earnings Guidance

Healthpeak Properties (NYSE:DOC) issued an update on its FY 2026 earnings guidance on Monday morning. The company provided EPS guidance of 1.700-1.740 for the period, compared to the consensus EPS estimate of 0.890. The company issued revenue guidance of -.

Healthpeak Properties Trading Down 1.9%

Shares of Healthpeak Properties stock traded down $0.33 during trading hours on Monday, hitting $16.91. The company’s stock had a trading volume of 11,688,549 shares, compared to its average volume of 9,792,884. The business has a fifty day moving average of $17.00 and a 200 day moving average of $17.65. Healthpeak Properties has a 1-year low of $15.71 and a 1-year high of $21.28. The company has a quick ratio of 1.22, a current ratio of 1.22 and a debt-to-equity ratio of 1.11. The company has a market capitalization of $11.75 billion, a PE ratio of -338.05, a P/E/G ratio of 4.34 and a beta of 1.12.

Healthpeak Properties (NYSE:DOC) last announced its quarterly earnings results on Monday, February 2nd. The real estate investment trust reported $0.16 earnings per share for the quarter, missing analysts’ consensus estimates of $0.45 by ($0.29). Healthpeak Properties had a negative return on equity of 0.44% and a negative net margin of 1.36%.The business had revenue of $719.40 million for the quarter, compared to analysts’ expectations of $685.14 million. Healthpeak Properties has set its FY 2026 guidance at 1.700-1.740 EPS. As a group, equities analysts forecast that Healthpeak Properties will post 1.86 EPS for the current year.

Healthpeak Properties Dividend Announcement

The business also recently announced a monthly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Tuesday, March 17th will be paid a $0.1017 dividend. The ex-dividend date is Tuesday, March 17th. This represents a c) dividend on an annualized basis and a dividend yield of 7.2%. Healthpeak Properties’s dividend payout ratio (DPR) is -2,440.00%.

Analysts Set New Price Targets

Several research firms recently commented on DOC. Wells Fargo & Company reduced their price target on Healthpeak Properties from $19.00 to $18.00 and set an “equal weight” rating on the stock in a research report on Monday. Cantor Fitzgerald set a $17.00 price target on shares of Healthpeak Properties in a report on Monday, January 5th. Robert W. Baird dropped their price target on shares of Healthpeak Properties from $21.00 to $20.00 and set an “outperform” rating on the stock in a research note on Wednesday, November 12th. Jefferies Financial Group cut shares of Healthpeak Properties from a “buy” rating to a “hold” rating and decreased their price objective for the company from $21.00 to $17.00 in a research report on Monday, December 15th. Finally, Weiss Ratings upgraded Healthpeak Properties from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Monday, January 26th. Six analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $19.58.

Institutional Trading of Healthpeak Properties

Hedge funds and other institutional investors have recently bought and sold shares of the company. CYBER HORNET ETFs LLC acquired a new position in shares of Healthpeak Properties in the 2nd quarter worth approximately $33,000. Wiser Advisor Group LLC bought a new position in Healthpeak Properties during the third quarter worth $38,000. Johnson Financial Group Inc. acquired a new position in Healthpeak Properties in the third quarter worth $78,000. Brown Brothers Harriman & Co. increased its stake in Healthpeak Properties by 80.4% during the third quarter. Brown Brothers Harriman & Co. now owns 5,039 shares of the real estate investment trust’s stock valued at $96,000 after purchasing an additional 2,245 shares during the last quarter. Finally, Binnacle Investments Inc raised its holdings in shares of Healthpeak Properties by 19.2% during the second quarter. Binnacle Investments Inc now owns 8,247 shares of the real estate investment trust’s stock worth $144,000 after purchasing an additional 1,327 shares during the period. 93.57% of the stock is owned by institutional investors.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.